Coverart for item
The Resource Cancer immunotherapy : paradigms, practice and promise, Tyler J. Curiel, editor, (electronic book)

Cancer immunotherapy : paradigms, practice and promise, Tyler J. Curiel, editor, (electronic book)

Label
Cancer immunotherapy : paradigms, practice and promise
Title
Cancer immunotherapy
Title remainder
paradigms, practice and promise
Statement of responsibility
Tyler J. Curiel, editor
Contributor
Subject
Language
eng
Summary
This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical trials are also discussed, as are key pre-clinical developments. The major challenges and intellectual issues facing investigators developing novel immunotherapeutics are discussed in detail as are conceptual developments influencing current and future treatment strategies. Each chapter begins by defining all relevant key terms and concepts and provides pertinent background information so that the text will be accessible to newcomers to the field as well as to the expert. This text book should provide an excellent reference resource for investigators in tumor immunology, life sciences students, drug developers designing novel anti-cancer immunotherapeutics, and to other individuals with some scientific training wishing to gain a better understanding of the field of tumor immunotherapy. Although the field is evolving rapidly, we have taken pains to ensure that information was as up to date as possible as the text went to press
Member of
Cataloging source
GW5XE
Dewey number
616.99/4061
Index
index present
LC call number
RC271.I45
LC item number
C36 2013
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
Curiel, Tyler J
http://library.link/vocab/subjectName
Cancer
Label
Cancer immunotherapy : paradigms, practice and promise, Tyler J. Curiel, editor, (electronic book)
Instantiates
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Part 1.
  • Overview
  • Historical Perspectives and Current Trends in Cancer Immunotherapy
  • Tyler J. Curiel
  • T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
  • Cailin Moira Wilke, Shuang Wei, Lin Wang, Ilona Kryczek and Jingyuan Fang, et al
  • Part 2.
  • Passive strategies to boost anti-tumor immunity
  • Adoptive T Cell Transfer
  • Donald R. Shaffer, Conrad Russell Y. Cruz and Cliona M. Rooney
  • Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
  • K.F. Bol, G. Schreibelt, E.H.J.G. Aarntzen, I.J.M. de Vries and C.G. Figdor
  • Immune Co-signaling to Treat Cancer
  • Margaret K. Callahan, Jedd D. Wolchok, James P. Allison and Padmanee Sharma
  • Managing Regulatory T Cells to Improve Cancer Immunotherapy
  • Tyler J. Curiel
  • Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives
  • Paulo C. Rodríguez and Augusto C. Ochoa
  • Antibodies as Cancer Immunotherapy
  • Devalingam Mahalingam and Tyler J. Curiel
  • Targeted Toxins in Cancer Immunotherapy
  • Devalingam Mahalingam, Michael J. Brumlik, Reinhard Waehler, David T. Curiel and Tyler J. Curiel
  • Part 3.
  • Active strategies to boost anti-tumor immunity
  • Peptide and Protein-Based Cancer Vaccines
  • Marion Braun, Rachel Perret, Godehard Scholz and Pedro Romero
  • Antigen Targeting to Dendritic Cells for Cancer Immunotherapy
  • Dinja Oosterhoff, David T. Curiel and Tanja D. de Gruijl
  • Cytokines in the Treatment of Cancer
  • Kim Margolin, Mark Lazarus and Howard L. Kaufman
  • Part 4.
  • Additional strategies and considerations
  • Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules
  • Robert S. Svatek and Tyler J. Curiel
  • Monitoring Antigen-Specific Responses in Clinical Trials of Cancer Immunotherapy
  • Audi G. Chapuis and Cassian Yee
  • Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies
  • Marijo Bilusic, Ravi A. Madan and James L. Gulley
Control code
SPR820362341
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781461447320
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
Quality assurance targets
not applicable
Reformatting quality
unknown
Reproduction note
Electronic resource.
Sound
unknown sound
Specific material designation
remote
Label
Cancer immunotherapy : paradigms, practice and promise, Tyler J. Curiel, editor, (electronic book)
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Part 1.
  • Overview
  • Historical Perspectives and Current Trends in Cancer Immunotherapy
  • Tyler J. Curiel
  • T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
  • Cailin Moira Wilke, Shuang Wei, Lin Wang, Ilona Kryczek and Jingyuan Fang, et al
  • Part 2.
  • Passive strategies to boost anti-tumor immunity
  • Adoptive T Cell Transfer
  • Donald R. Shaffer, Conrad Russell Y. Cruz and Cliona M. Rooney
  • Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
  • K.F. Bol, G. Schreibelt, E.H.J.G. Aarntzen, I.J.M. de Vries and C.G. Figdor
  • Immune Co-signaling to Treat Cancer
  • Margaret K. Callahan, Jedd D. Wolchok, James P. Allison and Padmanee Sharma
  • Managing Regulatory T Cells to Improve Cancer Immunotherapy
  • Tyler J. Curiel
  • Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives
  • Paulo C. Rodríguez and Augusto C. Ochoa
  • Antibodies as Cancer Immunotherapy
  • Devalingam Mahalingam and Tyler J. Curiel
  • Targeted Toxins in Cancer Immunotherapy
  • Devalingam Mahalingam, Michael J. Brumlik, Reinhard Waehler, David T. Curiel and Tyler J. Curiel
  • Part 3.
  • Active strategies to boost anti-tumor immunity
  • Peptide and Protein-Based Cancer Vaccines
  • Marion Braun, Rachel Perret, Godehard Scholz and Pedro Romero
  • Antigen Targeting to Dendritic Cells for Cancer Immunotherapy
  • Dinja Oosterhoff, David T. Curiel and Tanja D. de Gruijl
  • Cytokines in the Treatment of Cancer
  • Kim Margolin, Mark Lazarus and Howard L. Kaufman
  • Part 4.
  • Additional strategies and considerations
  • Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules
  • Robert S. Svatek and Tyler J. Curiel
  • Monitoring Antigen-Specific Responses in Clinical Trials of Cancer Immunotherapy
  • Audi G. Chapuis and Cassian Yee
  • Issues in Pre-clinical Models, Clinical Trial Design and Analytical Considerations in Developing and Evaluating Novel Cancer Immunotherapies
  • Marijo Bilusic, Ravi A. Madan and James L. Gulley
Control code
SPR820362341
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781461447320
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
Quality assurance targets
not applicable
Reformatting quality
unknown
Reproduction note
Electronic resource.
Sound
unknown sound
Specific material designation
remote

Library Locations

Processing Feedback ...